Developer docs
API playgroundTry for free, no card

Search company profiles

Eitan Medical

Full company profile

uuid0009kf7

Namestring
Eitan Medical
Legal namestring
Eitan Medical Ltd.
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Eitan Medical Ltd., founded in 2009 in Netanya, Israel (and previously known as Eitan Group), develops connected infusion therapy and drug delivery solutions for hospitals, home infusion providers, infusion centers, emergency medical services, and pharmaceutical combination-product partners. The company's hardware portfolio is anchored by two product lines: the Sapphire multi-therapy infusion pump family (Multi-Therapy, Epidural, and IVVet veterinary variants) featuring volumetric peristaltic pumping, multiple delivery modes including continuous, PCA, intermittent, multi-step, TPN, and epidural analgesia (PCEA, PIEB); and the Avoset connected ambulatory infusion pump, which combines compact hardware with Bluetooth/cellular connectivity and web-based PC programming. These devices are unified by Eitan Insights, a HIPAA- and GDPR-compliant cloud-based digital health platform (hosted on a French HDS-certified data center) that provides near real-time remote monitoring, treatment analytics, care planning support, GPS pump location tracking, and bidirectional integration with third-party clinical and asset management systems (AlayaCare, WeInfuse, InfuseTrack, Bainbridge Health).

Eitan Medical generates revenue through a mix of infusion pump hardware sales, recurring software/platform fees for Eitan Insights, pharmaceutical combination-product and licensing partnerships, and ancillary service, training, and maintenance contracts (Eitan Medical Academy, FasTest PM, Configuration Manager). The company sells through direct enterprise field sales teams in North America (Aliso Viejo, CA), the UK (Didcot), France (Marseille), and Germany, supplemented by a global distributor network. Pricing is quote-based and not publicly disclosed; the Avoset Pain Management System is offered via a single-patient-use kit model, allowing facilities to access therapy without owning pump inventory outright. In June 2023, Eitan Medical divested its Sorrel wearable injectors business to LTS LOHMANN Therapie-Systeme AG for $100 million, refocusing the company on its core connected infusion therapy portfolio. The company operates as part of the Eitan Group family alongside Q Core Medical and Avoset Health, with subsidiaries spanning Israel, the United States, the United Kingdom, and France, and is founder/investor-owned with no public listing.

Short descriptiontext

Eitan Medical is a privately held Israeli medical device company that develops connected infusion pump systems (Sapphire and Avoset) and a cloud-based digital health platform (Eitan Insights) for hospitals, home infusion providers, infusion centers, EMS, and pharmaceutical partners across global markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNetanya, Israel
HQ citystring
Netanya
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
infusion pump systems, drug delivery devices, connected healthcare solutions, medical device manufacturing, home infusion therapy
Industry3 codes
1Infusion Pumps (Ambulatory/Stationary)
CodeHLAHAIAFPrimaryYes
2Connected Therapeutics & Smart Drug Delivery Monitoring
CodeHLACAFALPrimaryNo
3Infusion & Home Infusion Pharmacy Services
CodeHLAFALAGPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Infusion Pumps & Drug Delivery Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Infusion Pump Hardware Sales
TypeHardware Sales
Description

Sale of Sapphire™ and Avoset™ infusion pumps and accessories. Revenue is generated from device sales to hospitals, home care providers, infusion centers, and EMS. The Avoset Pain Management System is offered through a single-patient-use kit model, which includes a reusable pump, sterile administration sets, and return packaging.

eitanmedical.com
2Software / Digital Health Platform
TypeSubscription Recurring
Description

Eitan Insights™ cloud platform provides remote treatment visibility, data analytics, and fleet management. Revenue derived from software subscriptions or platform access fees integrated with hardware sales.

eitanmedical.com
3Pharmaceutical Partnership / Combination Products
TypeLicensing Royalties
Description

Partnerships with pharmaceutical companies to provide drug delivery solutions for combination products, including supporting drug development and commercialization cycles.

eitanmedical.com
4Service, Support & Maintenance
TypeProfessional Services
Description

Service programs, training (Eitan Medical Academy), maintenance tools (FasTest PM, Pump Loader, Configuration Manager Tool), and customer support.

eitanmedical.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Avoset Pain Management System - Single-Patient-Use Kit Model
ModelOtherBilling cadenceMulti-year contract
Notes

Available through a service model that includes a reusable Avoset infusion pump, sterile administration set tubing, patient education materials, carrying pouch, and prepaid packaging for pump return after therapy completion. Facilities do not need to own or manage pump inventory. Pricing is quote-based and not publicly disclosed.

eitanmedical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1Sapphire
Description

Multi-therapy infusion pump platform for hospital, ambulatory, and home care settings, including Sapphire Multi-Therapy, Sapphire Epidural, and Sapphire IVVet (veterinary).

eitanmedical.com
+3 more records
Core offering1 text field

Eitan Medical designs, manufactures, and sells connected infusion pump systems and drug delivery solutions for hospital, ambulatory, and home care settings. Its flagship offerings include the Sapphire multi-therapy infusion pump family, the Avoset connected ambulatory infusion pump family (including the Avoset Pain Management System), and the Eitan Insights cloud-based digital health platform that provides remote monitoring, analytics, and bidirectional integration with clinical documentation systems. The company supports its hardware with service software tools, training (Eitan Medical Academy), and pharmaceutical combination product development partnerships.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduced hospital readmission rates for home infusion patients (reference: 34% baseline readmission rate cited by NHIA data, Eitan Insights aims to reduce through better monitoring)
+3 more records
Product overview1 text field

Eitan Medical offers a portfolio of connected infusion therapy solutions spanning hospital, ambulatory, and home care settings. The core product lines include the Sapphire infusion pump family (multi-therapy, epidural, and veterinary variants) and the Avoset connected infusion pump platform. These hardware platforms are unified by Eitan Insights, a cloud-based digital health platform that provides remote monitoring, treatment analytics, and care planning support. Sapphire Connect is a cellular accessory enabling cloud connectivity for the Sapphire line. The company also provides service software tools including FasTest PM for preventative maintenance, Pump Loader, Configuration Manager Tool, Drug Library Editor, Event Viewer, and Annual Certification Software. The Avoset Pain Management System extends the portfolio into post-surgical pain management for regional anesthesia. The overall architecture combines hardware pumps with software platforms to create connected infusion ecosystems.

Product and service5 records
1Sapphire Infusion Pump
CategoryMulti-therapy infusion pump hardware
Description

Multi-therapy infusion pump providing advanced infusion therapy systems in hospital, ambulatory, and home care settings. Features volumetric pump with peristaltic mechanism, multiple administration modes including continuous, PCA, intermittent, multi-step, TPN, and epidural therapies. Includes the Sapphire Multi-Therapy, Sapphire Epidural, and Sapphire IVVet (veterinary) variants.

2Avoset Infusion Pump
CategoryConnected ambulatory infusion pump hardware
Description

Connected ambulatory multi-therapy infusion pump designed for specialty and home infusion applications. Features compact design, Bluetooth connectivity, web-based PC programming, and integration with Eitan Insights platform for remote monitoring. Includes volumetric peristaltic pumping, one-click administration set, up to 280h battery life, and programmable intermittent bolus, PCA, and continuous basal rate modes.

3Avoset Pain Management System
CategoryPain management infusion system
Description

Connected infusion technology for post-surgical pain management using peripheral nerve block infusions in regional anesthesia. Features programmable intermittent bolus (PIB), patient-controlled analgesia (PCA), continuous basal rate, 24-hour delayed start, 0 mL/hr KVO, and single-patient-use kit model. Integrated with Eitan Insights platform for remote monitoring.

4Eitan Insights Digital Health Platform
CategoryCloud-based digital health software platform
Description

Cloud-based digital health platform providing remote treatment visibility, real-time infusion monitoring, treatment analytics, care planning support, GPS pump location tracking, and compliance monitoring. Integrates with Sapphire and Avoset infusion systems and supports bidirectional data exchange with third-party clinical documentation platforms (AlayaCare, WeInfuse, InfuseTrack, Bainbridge Health). Adopted by infusion providers worldwide across home infusion, hospital-at-home programs, infusion centers, and hospices.

5Sapphire Connect Cellular Accessory
CategoryInfusion pump connectivity accessory
Description

Universal plug-and-play cellular accessory for Sapphire pumps that enables cloud data transmission to Eitan Insights. Features rechargeable battery with USB-C charging that can also charge the host pump.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-16
Description

Strategic partnership for bidirectional data exchange between Eitan Medical's infusion pumps and WeInfuse's clinical documentation and asset management workflows. Pump data (start/stop times, rate changes) automatically flows into WeInfuse systems via Eitan Insights. Eitan Medical pumps also integrate with WeInfuse's InfuseTrack asset management platform for fleet tracking and preventive maintenance management.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-20
Description

Integration of Eitan Insights with AlayaCare's cloud-based home and community care platform, enabling automatic flow of pump data (flow rates, volumes delivered, therapy parameters) into clinical documentation in near real time. Eliminates manual transcription for home infusion nurses and reduces documentation time and transcription errors.

Strategic tierMajor DivestitureTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2023-06-01
Description

In June 2023, LTS LOHMANN Therapie-Systeme AG (Germany) acquired the Sorrel wearable injection device business from Eitan Medical for $100 million, strengthening LTS's drug delivery portfolio for large molecules and biologics. The transaction completed Eitan Medical's strategic focus on its core infusion therapy portfolio.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-11-01
Description

Eitan Medical was welcomed to NHIA's Future of Infusion Advisory Council, contributing to industry thought leadership on the evolution of home infusion care delivery.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-01
Description

Sorrel Medical (now divested to LTS) entered strategic partnerships with pharmaceutical companies for next-generation wearable drug delivery solutions across various molecule development initiatives. Eitan Medical continues to serve pharma partnerships through its pharmaceutical solutions division.

Strategic tierHistoricalTypeStrategic or Co-development PartnerAnnounced on2011-01-01
Description

Strategic R&D partnership with Hospira for the Sapphire infusion pump, including FDA 510(k) clearance support. Hospira was later acquired by Pfizer (2015).

Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Medtronic is a broad incumbent with its Patient Monitoring and insulin delivery businesses, offering connected therapy platforms that intersect with Eitan's connected infusion and remote monitoring strategy in the broader drug delivery space.

TypeDirect peer
Description

ICU Medical (including the acquired Smiths Medical infusion pump portfolio) is a direct competitor offering multi-therapy infusion pumps (Plum 360, LifeCare PCA) for hospital and ambulatory settings, competing head-to-head with Eitan's Sapphire and Avoset lines.

TypeDirect peer
Description

B. Braun is a direct competitor offering the Infusomat, Perfusor, and SpaceStation infusion platforms for hospitals and home care, with global scale, infusion service programs, and home infusion capabilities overlapping with Eitan's portfolio.

TypeDirect peer
Description

Baxter is a direct competitor in infusion therapy with its Sigma Spectrum and Novum infusion pumps, plus extensive US hospital contracts and a global distribution network that overlaps with Eitan's hospital and home infusion footprint.

TypeBroad incumbent
Description

BD is a broad incumbent in medication delivery and infusion disposables, offering infusion sets, syringes, and connected administration solutions that overlap with Eitan's consumable and connected-therapy offerings.

TypeOthers
Description

AlayaCare is a software/integration partner rather than a competitor, but its home and community care platform directly integrates with Eitan Insights, making it an ecosystem peer shaping how connected infusion data reaches home care providers.

TypeDirect peer
Description

Moog's medical devices division produces infusion pumps (Curlin, CADD) for ambulatory and home infusion markets, directly comparable to Eitan's Avoset line in specialty and home infusion therapy.

TypeDirect peer
Description

Fresenius Kabi is a direct competitor in infusion pumps (Ivenix, Volumat, Agilia) and a major home infusion provider, competing with Eitan both as a device manufacturer and as an integrated infusion service provider.

TypeEmerging player
Description

Mindray is an emerging competitor in infusion pumps (eSP, BeneFusion series) with growing international presence, offering cost-competitive multi-therapy pumps that increasingly compete with Sapphire in emerging and price-sensitive markets.

TypeDirect peer
Description

Terumo is a direct competitor with its Terufusion and TE-SS800 infusion pump families, plus strong presence in hospital infusion therapy across Asia, Europe, and the Americas, comparable to Eitan's multi-therapy offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles17 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Eitan Medical

Medical Infusion Pumps & Drug Delivery Deviceseitanmedical.com

Eitan Medical is a privately held Israeli medical device company that develops connected infusion pump systems (Sapphire and Avoset) and a cloud-based digital health platform (Eitan Insights) for hospitals, home infusion providers, infusion centers, EMS, and pharmaceutical partners across global markets.

What Eitan Medical does

Eitan Medical Ltd., founded in 2009 in Netanya, Israel (and previously known as Eitan Group), develops connected infusion therapy and drug delivery solutions for hospitals, home infusion providers, infusion centers, emergency medical services, and pharmaceutical combination-product partners. The company's hardware portfolio is anchored by two product lines: the Sapphire multi-therapy infusion pump family (Multi-Therapy, Epidural, and IVVet veterinary variants) featuring volumetric peristaltic pumping, multiple delivery modes including continuous, PCA, intermittent, multi-step, TPN, and epidural analgesia (PCEA, PIEB); and the Avoset connected ambulatory infusion pump, which combines compact hardware with Bluetooth/cellular connectivity and web-based PC programming. These devices are unified by Eitan Insights, a HIPAA- and GDPR-compliant cloud-based digital health platform (hosted on a French HDS-certified data center) that provides near real-time remote monitoring, treatment analytics, care planning support, GPS pump location tracking, and bidirectional integration with third-party clinical and asset management systems (AlayaCare, WeInfuse, InfuseTrack, Bainbridge Health).

Eitan Medical generates revenue through a mix of infusion pump hardware sales, recurring software/platform fees for Eitan Insights, pharmaceutical combination-product and licensing partnerships, and ancillary service, training, and maintenance contracts (Eitan Medical Academy, FasTest PM, Configuration Manager). The company sells through direct enterprise field sales teams in North America (Aliso Viejo, CA), the UK (Didcot), France (Marseille), and Germany, supplemented by a global distributor network. Pricing is quote-based and not publicly disclosed; the Avoset Pain Management System is offered via a single-patient-use kit model, allowing facilities to access therapy without owning pump inventory outright. In June 2023, Eitan Medical divested its Sorrel wearable injectors business to LTS LOHMANN Therapie-Systeme AG for $100 million, refocusing the company on its core connected infusion therapy portfolio. The company operates as part of the Eitan Group family alongside Q Core Medical and Avoset Health, with subsidiaries spanning Israel, the United States, the United Kingdom, and France, and is founder/investor-owned with no public listing.

Eitan Medical firmographics

Firmographics
Name
Eitan Medical
Legal name
Eitan Medical Ltd.
Website
https://eitanmedical.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
251–500 employees
Short description
Eitan Medical is a privately held Israeli medical device company that develops connected infusion pump systems (Sapphire and Avoset) and a cloud-based digital health platform (Eitan Insights) for hospitals, home infusion providers, infusion centers, EMS, and pharmaceutical partners across global markets.
Ownership category
akta.pro rank

Eitan Medical industry classification

Industry
Product category
Medical Infusion Pumps & Drug Delivery Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Infusion Pumps (Ambulatory/Stationary) (HLAHAIAF)
akta.pro secondary industries
Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Infusion & Home Infusion Pharmacy Services (HLAFALAG)

Keywords

  • Infusion pump systems
  • Drug delivery devices
  • Connected healthcare solutions
  • Medical device manufacturing
  • Home infusion therapy

Where Eitan Medical is headquartered

Location

Headquarters

HQ city
Netanya
HQ country
Israel
HQ region
Middle East

Offices4 records

Markets served

Eitan Medical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Infusion Pump Hardware Sales: Sale of Sapphire™ and Avoset™ infusion pumps and accessories. Revenue is generated from device sales to hospitals, home care providers, infusion centers, and EMS. The Avoset Pain Management System is offered through a single-patient-use kit model, which includes a reusable pump, sterile administration sets, and return packaging.
  2. Software / Digital Health Platform: Eitan Insights™ cloud platform provides remote treatment visibility, data analytics, and fleet management. Revenue derived from software subscriptions or platform access fees integrated with hardware sales.
  3. Pharmaceutical Partnership / Combination Products: Partnerships with pharmaceutical companies to provide drug delivery solutions for combination products, including supporting drug development and commercialization cycles.
  4. Service, Support & Maintenance: Service programs, training (Eitan Medical Academy), maintenance tools (FasTest PM, Pump Loader, Configuration Manager Tool), and customer support.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractAvoset Pain Management System - Single-Patient-Use Kit Model

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Eitan Medical product offering

Product offering

Core offering

Eitan Medical designs, manufactures, and sells connected infusion pump systems and drug delivery solutions for hospital, ambulatory, and home care settings. Its flagship offerings include the Sapphire multi-therapy infusion pump family, the Avoset connected ambulatory infusion pump family (including the Avoset Pain Management System), and the Eitan Insights cloud-based digital health platform that provides remote monitoring, analytics, and bidirectional integration with clinical documentation systems. The company supports its hardware with service software tools, training (Eitan Medical Academy), and pharmaceutical combination product development partnerships.

Product overview

Eitan Medical offers a portfolio of connected infusion therapy solutions spanning hospital, ambulatory, and home care settings. The core product lines include the Sapphire infusion pump family (multi-therapy, epidural, and veterinary variants) and the Avoset connected infusion pump platform. These hardware platforms are unified by Eitan Insights, a cloud-based digital health platform that provides remote monitoring, treatment analytics, and care planning support. Sapphire Connect is a cellular accessory enabling cloud connectivity for the Sapphire line. The company also provides service software tools including FasTest PM for preventative maintenance, Pump Loader, Configuration Manager Tool, Drug Library Editor, Event Viewer, and Annual Certification Software. The Avoset Pain Management System extends the portfolio into post-surgical pain management for regional anesthesia. The overall architecture combines hardware pumps with software platforms to create connected infusion ecosystems.

Differentiator

Problem solved

Functional benefit

Brands

  • Sapphire: Multi-therapy infusion pump platform for hospital, ambulatory, and home care settings, including Sapphire Multi-Therapy, Sapphire Epidural, and Sapphire IVVet (veterinary).
  • Avoset
  • Eitan Insights
  • Sapphire Connect

Products and services

  • Sapphire Infusion Pump Multi-therapy infusion pump providing advanced infusion therapy systems in hospital, ambulatory, and home care settings. Features volumetric pump with peristaltic mechanism, multiple administration modes including continuous, PCA, intermittent, multi-step, TPN, and epidural therapies. Includes the Sapphire Multi-Therapy, Sapphire Epidural, and Sapphire IVVet (veterinary) variants.
  • Avoset Infusion Pump Connected ambulatory multi-therapy infusion pump designed for specialty and home infusion applications. Features compact design, Bluetooth connectivity, web-based PC programming, and integration with Eitan Insights platform for remote monitoring. Includes volumetric peristaltic pumping, one-click administration set, up to 280h battery life, and programmable intermittent bolus, PCA, and continuous basal rate modes.
  • Avoset Pain Management System Connected infusion technology for post-surgical pain management using peripheral nerve block infusions in regional anesthesia. Features programmable intermittent bolus (PIB), patient-controlled analgesia (PCA), continuous basal rate, 24-hour delayed start, 0 mL/hr KVO, and single-patient-use kit model. Integrated with Eitan Insights platform for remote monitoring.
  • Eitan Insights Digital Health Platform Cloud-based digital health platform providing remote treatment visibility, real-time infusion monitoring, treatment analytics, care planning support, GPS pump location tracking, and compliance monitoring. Integrates with Sapphire and Avoset infusion systems and supports bidirectional data exchange with third-party clinical documentation platforms (AlayaCare, WeInfuse, InfuseTrack, Bainbridge Health). Adopted by infusion providers worldwide across home infusion, hospital-at-home programs, infusion centers, and hospices.
  • Sapphire Connect Cellular Accessory Universal plug-and-play cellular accessory for Sapphire pumps that enables cloud data transmission to Eitan Insights. Features rechargeable battery with USB-C charging that can also charge the host pump.

Quantifiable outcome

  • Reduced hospital readmission rates for home infusion patients (reference: 34% baseline readmission rate cited by NHIA data, Eitan Insights aims to reduce through better monitoring)
  • +3 more outcomes

Companies that use Eitan Medical

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles4 records

Eitan Medical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Eitan Medical partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major divestiture, minor and historical.

  • WeInfusecoreTechnology or Integration · 16 June 2026Strategic partnership for bidirectional data exchange between Eitan Medical's infusion pumps and WeInfuse's clinical documentation and asset management workflows. Pump data (start/stop times, rate changes) automatically flows into WeInfuse systems via Eitan Insights. Eitan Medical pumps also integrate with WeInfuse's InfuseTrack asset management platform for fleet tracking and preventive maintenance management.
  • AlayaCarecoreTechnology or Integration · 20 April 2026Integration of Eitan Insights with AlayaCare's cloud-based home and community care platform, enabling automatic flow of pump data (flow rates, volumes delivered, therapy parameters) into clinical documentation in near real time. Eliminates manual transcription for home infusion nurses and reduces documentation time and transcription errors.
  • LTS LOHMANN Therapie-Systeme AG (LTS)major divestitureOEM/ Whitelabel/ Licensing Partner · 1 June 2023In June 2023, LTS LOHMANN Therapie-Systeme AG (Germany) acquired the Sorrel wearable injection device business from Eitan Medical for $100 million, strengthening LTS's drug delivery portfolio for large molecules and biologics. The transaction completed Eitan Medical's strategic focus on its core infusion therapy portfolio.
  • National Home Infusion Association (NHIA) - Future of Infusion Advisory CouncilminorStrategic or Co-development Partner · 1 November 2021Eitan Medical was welcomed to NHIA's Future of Infusion Advisory Council, contributing to industry thought leadership on the evolution of home infusion care delivery.
  • Global Pharmaceutical Manufacturer (multiple)coreStrategic or Co-development Partner · 1 July 2020Sorrel Medical (now divested to LTS) entered strategic partnerships with pharmaceutical companies for next-generation wearable drug delivery solutions across various molecule development initiatives. Eitan Medical continues to serve pharma partnerships through its pharmaceutical solutions division.
  • HospirahistoricalStrategic or Co-development Partner · 1 January 2011Strategic R&D partnership with Hospira for the Sapphire infusion pump, including FDA 510(k) clearance support. Hospira was later acquired by Pfizer (2015).

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Eitan Medical competitors and assessment

Company assessment

Broad incumbents

  • Medtronic: Medtronic is a broad incumbent with its Patient Monitoring and insulin delivery businesses, offering connected therapy platforms that intersect with Eitan's connected infusion and remote monitoring strategy in the broader drug delivery space.
  • Becton Dickinson (BD): BD is a broad incumbent in medication delivery and infusion disposables, offering infusion sets, syringes, and connected administration solutions that overlap with Eitan's consumable and connected-therapy offerings.

Direct peers

  • ICU Medical: ICU Medical (including the acquired Smiths Medical infusion pump portfolio) is a direct competitor offering multi-therapy infusion pumps (Plum 360, LifeCare PCA) for hospital and ambulatory settings, competing head-to-head with Eitan's Sapphire and Avoset lines.
  • B. Braun Medical: B. Braun is a direct competitor offering the Infusomat, Perfusor, and SpaceStation infusion platforms for hospitals and home care, with global scale, infusion service programs, and home infusion capabilities overlapping with Eitan's portfolio.
  • Baxter International: Baxter is a direct competitor in infusion therapy with its Sigma Spectrum and Novum infusion pumps, plus extensive US hospital contracts and a global distribution network that overlaps with Eitan's hospital and home infusion footprint.
  • Moog Inc. Moog's medical devices division produces infusion pumps (Curlin, CADD) for ambulatory and home infusion markets, directly comparable to Eitan's Avoset line in specialty and home infusion therapy.
  • Fresenius Kabi: Fresenius Kabi is a direct competitor in infusion pumps (Ivenix, Volumat, Agilia) and a major home infusion provider, competing with Eitan both as a device manufacturer and as an integrated infusion service provider.
  • Terumo: Terumo is a direct competitor with its Terufusion and TE-SS800 infusion pump families, plus strong presence in hospital infusion therapy across Asia, Europe, and the Americas, comparable to Eitan's multi-therapy offerings.

Others

  • AlayaCare: AlayaCare is a software/integration partner rather than a competitor, but its home and community care platform directly integrates with Eitan Insights, making it an ecosystem peer shaping how connected infusion data reaches home care providers.

Emerging players

  • Mindray: Mindray is an emerging competitor in infusion pumps (eSP, BeneFusion series) with growing international presence, offering cost-competitive multi-therapy pumps that increasingly compete with Sapphire in emerging and price-sensitive markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Eitan Medical social profiles

Digital presence

Eitan Medical compliance and trust

Trust signal

Compliance4 records

Eitan Medical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Eitan Medical leadership team

Management profile

Number of profiles

Profiles17 records

Eitan Medical subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Eitan Medical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Eitan Medical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eitan Medical

What does Eitan Medical do?

Eitan Medical designs, manufactures, and sells connected infusion pump systems and drug delivery solutions for hospital, ambulatory, and home care settings. Its flagship offerings include the Sapphire multi-therapy infusion pump family, the Avoset connected ambulatory infusion pump family (including the Avoset Pain Management System), and the Eitan Insights cloud-based digital health platform that provides remote monitoring, analytics, and bidirectional integration with clinical documentation systems. The company supports its hardware with service software tools, training (Eitan Medical Academy), and pharmaceutical combination product development partnerships.

Is Eitan Medical a public or private company?

Eitan Medical is a private company. It is classified as family owned and is currently operating.

When was Eitan Medical founded?

Eitan Medical was founded in 2009. It employs 251 to 500 people.

Where is Eitan Medical based?

Eitan Medical is headquartered in Netanya, Israel, in the Middle East region.

How does Eitan Medical make money?

Four revenue lines are on record. Infusion Pump Hardware Sales are the primary driver. The others are software / Digital Health Platform, pharmaceutical Partnership / Combination Products and service, Support & Maintenance.

Who are Eitan Medical's main competitors?

Broad incumbents on record are Medtronic and Becton Dickinson (BD). Direct peers are ICU Medical, B. Braun Medical, Baxter International, Moog Inc., Fresenius Kabi and Terumo. AlayaCare is listed as an others. Mindray is listed as an emerging player.

Does Eitan Medical have an API?

No public API is recorded for Eitan Medical.

What industry is Eitan Medical in?

Eitan Medical's product category is Medical Infusion Pumps & Drug Delivery Devices. Its primary akta.pro industry code is HLAHAIAF, Infusion Pumps (Ambulatory/Stationary), with a secondary code of HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAutomating Infusion Care: Eitan Medical and WeInfuse Deliver Seamless Pump-to-Workflow IntegrationWeInfuse announced a strategic partnership with Eitan Medical to integrate their software platforms, enabling bidirectional data exchange between Eitan Medical's infusion pumps and WeInfuse's clinical documentation and asset management workflows. The integration will automatically flow pump data such as start/stop times and rate changes into WeInfuse's systems, reducing manual documentation and administrative burden on clinicians. Both companies cited the partnership as a step toward creating connected infusion ecosystems that improve documentation accuracy and allow providers to focus more time on patient care.GlobeNewswireAlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nursesAlayaCare and Eitan Medical announced a partnership integrating Eitan Medical's infusion pump data directly into AlayaCare's clinical documentation, eliminating manual transcription for home infusion nurses. The integration aims to reduce documentation time and errors, freeing nurses to focus on patient care. Home infusion agencies using AlayaCare can deploy Eitan Medical pumps with automatic data reflection.GlobeNewswireAlayaCare and Eitan Medical partner to eliminate manual transcription for home infusion nursesAlayaCare and Eitan Medical announced a strategic partnership to integrate Eitan Insights, a cloud-based digital health solution, with AlayaCare's cloud-based home and community care platform. The integration enables infusion pump data, including flow rates, volumes delivered, and therapy parameters, to automatically flow into clinical documentation in near real time, eliminating the need for nurses to manually transcribe readings. By connecting device data directly to documentation, the partnership aims to reduce documentation time, minimize transcription errors, and free up nurses to focus on patient care rather than administrative tasks.PR NewswireEitan Medical Introduces the Avoset® Pain Management System to the U.S. Regional Anesthesia Market, Bringing Connected Infusion Technology for Post-Surgical Pain ManagementEitan Medical announced the U.S. launch of its Avoset® Pain Management System, a connected infusion technology designed for post-surgical pain management using peripheral nerve block infusions in regional anesthesia. The system features an electronic pump with programmable intermittent bolus, patient-controlled analgesia, and continuous basal rate capabilities, offered through a single-patient-use kit model without requiring facilities to own pump inventory. The product is available exclusively in the United States and is integrated with Eitan Insights®, the company's digital health platform for remote treatment data visibility.openPR.comMarket Trend Insights: The Impact of Recent Innovations on the Wearable Infusion Pumps MarketThe wearable infusion pumps market is projected to reach $2.36 billion by 2030, growing at a compound annual growth rate of 9.3%, driven by AI-powered dose optimization, smartphone integration, and multi-drug delivery systems. A notable transaction in June 2023 saw Germany's Lohmann Therapie-Systeme AG acquire Sorrel from Eitan Medical for $100 million to strengthen its drug delivery portfolio, while UAE's GulfDrug LLC launched the EOPatch tubeless insulin pump in February 2023. The article serves as a promotional market report from The Business Research Company outlining industry trends, key players, and segmentation.openPR.comTop Players and Competitive Dynamics in the Wearable Injectors MarketThe global wearable injectors market is projected to grow to $19.77 billion by 2030, representing a compound annual growth rate of 15.0%, driven by increasing adoption of personalized medicine, home-based care, and connected drug delivery platforms. In June 2023, Germany-based LTS LOHMANN Therapie-Systeme AG acquired the Sorrel wearable injection device business from Israel's Eitan Medical Ltd., strengthening LTS LOHMANN's drug delivery portfolio for large molecules and biologics. In February 2024, US-based Coherus BioSciences Inc. launched UDENYCA, a drug delivery device built on the LTS Sorrel wearable platform enabling patients to self-administer medication at home.openPR.comLeading Companies Enhancing Their Presence in the Patient Controlled Injectors MarketThe global patient controlled injectors market is projected to reach $8.72 billion by 2030, growing at a compound annual growth rate of 11.1%, driven by connected drug delivery systems, personalized medicine, and increased home-based therapies. In April 2023, Germany-based LTS Lohmann Therapie-Systeme AG acquired the Sorrel wearable injection device business from Israel's Eitan Medical to strengthen its advanced wearable injection portfolio. In October 2023, U.S.-based Apellis Pharmaceuticals received FDA approval for its Empavelir Injector Device, a patient-controlled on-body injector for at-home administration of pegcetacoplan.NoCamelsTop German Pharma Firm Buys Israeli Wearable Drug DispenserA German pharmaceutical company, LTS, acquired the Israeli startup Eitan Medical's Sorrel wearable injector business. The move aligns with Eitan Medical's strategic focus on infusion therapy products. The acquisition aims to enhance LTS's capabilities in drug delivery for large molecules.LtslohmannLTS completes its entry into large molecule drug deliveryLTS LOHMANN Therapie-Systeme AG has completed the acquisition of the Sorrel wearable injection device business from Eitan Medical Ltd. This strategic move expands LTS's capabilities into large molecule drug delivery, integrating Sorrel as a new division named LTS Device Technologies. The transaction aims to provide pharma partners with advanced wearable solutions for biologics that require in-clinic administration or multiple injections.PR NewswireEitan Medical Completes Transition of Wearable Injectors BusinessEitan Medical has completed the sale and transition of its wearable injectors business to LTS LOHMANN Therapie-Systeme AG, a pharmaceutical technology company. The acquisition enables LTS to expand its drug delivery portfolio with connected, pre-filled wearable devices designed for subcutaneous delivery of large molecule drugs. Eitan Medical will now concentrate on its core infusion therapy portfolio, including its recently launched Avoset Infusion Platform for post-acute care.